Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ILLUMINA, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-12-29 to 2024-06-12
Current total value of award: $22467.76
Description: NEXT GENERATION SEQUENCING REAGENTS PROVIDING HIGH RESOLUTION DEOXYRIBONUCLEIC HUMAN LEUKOCYTE ANTIGEN TYPING FOR BOTH TRANSPLANT RECIPIENTS AND DONORS.